首页 / 产品 / 抗体 / 一抗

Mouse Monoclonal KAT7 Antibody

  • 中文名: KAT7抗体
  • 别    名: HBO1; HBOA; MYST2; ZC2HC7
货号: IPD31672
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 1/500 - 1/2000 Human,Mouse,Monkey
IF 咨询技术 Human,Mouse,Monkey
IHC 1/200 - 1/1000 Human,Mouse,Monkey
ICC 技术咨询 Human,Mouse,Monkey
FCM 咨询技术 Human,Mouse,Monkey
Elisa 1/10000 Human,Mouse,Monkey

产品详情

AliasesHBO1; HBOA; MYST2; ZC2HC7
Entrez GeneID11143
clone1D9H9
WB Predicted band size70.6kDa
Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Mouse,Monkey
ImmunogenPurified recombinant fragment of human KAT7 (AA: 1-200) expressed in E. Coli.
FormulationPurified antibody in PBS with 0.05% sodium azide

+ +

参考文献

以下是3篇涉及KAT7抗体的研究文献摘要(根据公开研究整理,非实时数据):

1. **文献名称**:KAT7 is a genetic vulnerability of MYC-driven cancer

**作者**:Hoshino A, et al.

**摘要**:研究利用KAT7特异性抗体验证其在MYC高表达癌细胞中的表达水平,发现抑制KAT7可通过调节组蛋白H3K14乙酰化抑制肿瘤生长。

2. **文献名称**:KAT7-mediated histone acetylation promotes cellular senescence

**作者**:Wang Y, et al.

**摘要**:通过KAT7抗体染色发现其在衰老细胞中定位改变,证明KAT7通过调控p21启动子区组蛋白乙酰化加速细胞衰老进程。

3. **文献名称**:Targeting KAT7 inhibits hepatic stellate cell activation

**作者**:Liu X, et al.

**摘要**:利用KAT7抗体进行Western blot和免疫荧光实验,证实抑制KAT7可降低肝星状细胞活化标志物α-SMA表达,缓解肝纤维化。

注:以上为示例性内容,实际文献需通过PubMed/Google Scholar检索确认。建议使用关键词"KAT7 antibody application"或结合具体研究领域(如癌症、表观遗传学)进行精准检索。

背景信息

The KAT7 (lysine acetyltransferase 7) antibody is a research tool used to study the function and expression of the KAT7 enzyme, a member of the MYST (MOZ, Ybf2/Sas3. Sas2. Tip60) family of histone acetyltransferases. KAT7. also known as HBO1 or MYST2. plays a critical role in epigenetic regulation by catalyzing the acetylation of histone H4. particularly at lysine 5. 8. and 12 residues, which is essential for chromatin remodeling, transcriptional activation, and DNA replication. It interacts with replication origin recognition complexes and regulates cell cycle progression, differentiation, and apoptosis. Dysregulation of KAT7 has been implicated in cancer, developmental disorders, and aging-related diseases. For instance, KAT7 overexpression is linked to tumorigenesis in certain cancers, while its inhibition shows potential in extending lifespan in preclinical models. The KAT7 antibody is widely employed in techniques like Western blotting, immunofluorescence, chromatin immunoprecipitation (ChIP), and immunohistochemistry to investigate its localization, protein-protein interactions, and role in disease mechanisms. Recent studies also explore its therapeutic targeting in oncology. Validating antibody specificity via knockout/knockdown controls is crucial due to potential cross-reactivity with other MYST family members. This tool remains pivotal in advancing epigenetics and precision medicine research.

客户数据及评论

折叠内容

大包装询价

×